| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1c89ce4d9ac03f9acd8ddede1162f94d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_661c68977a99ccd5a68ea29d1b870a1b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d8b902ff4296a6be4fee70d6ccac29f7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9e96a7912a4e01334aca3ffd3babe863
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_402e17b93864b223544273eef4003cb3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_25a7031cde5cefa9e3c756d0bedc2001
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_51b7f64f380c538d4b6aa024f05455da |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-14 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4525
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-454
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-422 |
| filingDate |
2014-08-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bcda920771c7a1ed9c9fbf86393875d1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_604571e9dc0a2da1e05cb2c92d6baa16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_50d36b12470adc164b1e4df336b730e8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cd74d0f9d385a12dd21d89376358b355
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_44f3248ec0bda56c7fe41749f8cd0252
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_16c2854d218ae6f71cf2493c807d9161 |
| publicationDate |
2015-02-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2015020930-A1 |
| titleOfInvention |
Oxazole orexin receptor antagonists |
| abstract |
The present invention is directed to oxazole compounds which are antagonists of orexin receptors. The present invention is also directed to uses of the oxazole compounds described herein in the potential treatment or prevention of neurological and psychiatric disorders and diseases in which orexin receptors are involved. The present invention is also directed to pharmaceutical compositions comprising these compounds. The present invention is also directed to uses of these pharmaceutical compositions in the prevention or treatment of such diseases in which orexin receptors are involved. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9920038-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016089721-A1 |
| priorityDate |
2013-08-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |